Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

AMANTADINE HCL

All products: general benefit

Other products in the same Health Canada class (N04B) — coverage varies; not interchangeable

  • Bromocriptine (Parlodel): general benefit, Not a benefit
  • Benserazide + levodopa (Prolopa 50-12.5): general benefit
  • Carbidopa + levodopa (Sinemet CR): general benefit, Limited Use, Not a benefit
  • Ropinirole (ReQuip): general benefit, Not a benefit
  • Selegiline (Eldepryl): general benefit, Not a benefit
  • Carbidopa + entacapone + levodopa (Stalevo): limited Use 367

PDP-Amantadine Hydrochloride Capsules · DIN 01990403 · 100mg · capsule

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
PDP-Amantadine Hydrochloride Capsules · DIN 01990403 Manufacturer: Pendopharm, Division of Pharmascience Inc.; listing date 1999-04-15 Health Canada: Marketed since 2017-03-15 · brand PDP-AMANTADINE HYDROCHLORIDE CAPSULES · ATC N04BB01 AMANTADINE, N04BB01 AMANTADINE · form Capsule · route Oral · ingredients AMANTADINE HYDROCHLORIDE 100 MG · company Pendopharm division of pharmascience inc · schedule Prescription
Check this DIN again · Health Canada product record

PDP-Amantadine Hydrochloride Capsules: Formulary list price $0.5662/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.5662 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13464 · Verify on the e-Formulary ↗ (DIN 01990403)

Source record
DIN 01990403: PDP-Amantadine Hydrochloride Capsules Raw flags: sec3=Y Item: 920000021; group id 895; item number 2148; lccId None; manufacturer id PEN Source form: Cap; strength: 100mg Recorded listing: General benefit Source prices (unrounded): $0.5662; ministry $0.5662 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=01990403 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13464
Interchangeable products
Symmetrel · DIN 01914006 · not recorded
Shortage status: resolved shortage (ended 2018-02-09); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=01990403
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Other drugs in the same formulary class (92:00 UNCLASSIFIED THERAPEUTIC AGENTS) and how they are covered

Matched class: 92:00 UNCLASSIFIED THERAPEUTIC AGENTS

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: ALENDRONATE & CHOLECALCIFEROL, AZATHIOPRINE, CYCLOSPORINE, GLUCAGON RDNA ORIGIN, LANREOTIDE ACETATE, LEFLUNOMIDE, LEVODOPA & BENSERAZIDE, MYCOPHENOLATE SODIUM Some products covered without a code (check the product listing): ALENDRONATE, ALLOPURINOL, BROMOCRIPTINE, CLOPIDOGREL BISULFATE, LEVODOPA & CARBIDOPA, MYCOPHENOLATE MOFETIL, OCTREOTIDE, RISEDRONATE SODIUM, ROPINIROLE, SELEGILINE HCL, TAMSULOSIN HCL 92:00 UNCLASSIFIED THERAPEUTIC AGENTS

BROMOCRIPTINE

· 4 products · Listed, not a benefit (2), General benefit (2) · strengths: 5mg, 2.5mg · Cap, Tab

LEVODOPA & BENSERAZIDE

· 3 products · General benefit · strengths: 50mg & 12.5mg, 100mg & 25mg, 200mg & 50mg · Cap

LEVODOPA & CARBIDOPA

· 25 products · Listed, not a benefit (5), Limited Use, codes 64, 65 (2), General benefit (18) · strengths: 100mg & 25mg, 200mg & 50mg, 100mg & 10mg, 250mg & 25mg · CR Tab, Tab

ROPINIROLE

· 12 products · Listed, not a benefit (4), General benefit (8) · strengths: 0.25mg, 1mg, 2mg, 5mg · Tab

SELEGILINE HCL

· 2 products · Listed, not a benefit (1), General benefit (1) · strengths: 5mg · Tab

LEVODOPA & CARBIDOPA & ENTACAPONE

· 5 products · Limited Use, codes 367 · strengths: 75 & 18.75 & 200mg, 125 & 31.25 & 200mg, 50 & 12.5 & 200mg, 100 & 25 & 200mg, 150 & 37.5 & 200mg · Tab

ALENDRONATE

· 28 products · Off-Formulary Interchangeable, not an ODB benefit (4), Listed, not a benefit (1), General benefit (23) · strengths: 5mg, 10mg, 70mg · Tab

ALENDRONATE & CHOLECALCIFEROL

· 6 products · General benefit · strengths: 70mg & 70mcg, 70mg & 140mcg · Tab

ALLOPURINOL

· 10 products · General benefit (6), Listed, not a benefit (4) · strengths: 100mg, 200mg, 300mg · Tab

AZATHIOPRINE

· 3 products · General benefit · strengths: 50mg · Tab

CLOPIDOGREL BISULFATE

· 19 products · General benefit (16), Off-Formulary Interchangeable, not an ODB benefit (3) · strengths: 75mg, 300mg · Tab

CYCLOSPORINE

· 8 products · General benefit · strengths: 10mg, 25mg, 50mg, 100mg, 100mg/mL · Cap, O/L Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 92:00 and 75 more
Full class listing Related classes: Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
1 INDICATIONS Antiparkinsonian Treatment pdp-AMANTADINE HYDROCHLORIDE is useful in the treatment of Parkinson's Syndrome and in the short-term management of drug-induced extrapyramidal symptoms. Antiviral Prevention and Treatment  The prevention or chemoprophylaxis of respiratory tract infections caused by Influenza A virus strains, especially in high-risk patients (including those with cardiopulmonary disease, neuromuscular disorders, the elderly, immunocompromised), close household or hospital ward contact of index cases, and those in critical public service positions (e.g. police, firefighters, and medical personnel). In the prophylaxis of influenza early vaccination is the method of choice. When early vaccination is not feasible, or when the vaccine is contraindicated or not available, amantadine hydrochloride may be used for chemoprophylaxis against influenza A virus illness. It is effective against all strains of Influenza A virus which have been tested to date. Because amantadine hydrochloride does not appear to suppress antibody response, it may be given as chemoprophylaxis concurrently with inactivated Influenza A virus vaccine until prot… https://pdf.hres.ca/dpd_pm/00066300.PDF PM date: Jun 13, 2022 Source product: PDP-AMANTADINE HYDROCHLORIDE CAPSULES; DIN 01990403; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.